Omicron Biochemicals, Inc. develops new and improved methods to
introduce stable isotopes, primarily 13C, 2H, 15N and 18O, into
biologically-important compounds. We specialize in the synthesis of
labeled carbohydrates, nucleosides, and their derivatives, but will
undertake the synthesis of other classes of compounds on a custom basis.
Our particular strengths lie in the preparation of site-specifically
labeled compounds, but we are also capable of producing uniformly
labeled products.
The approaches used in synthesis include chemical, chemi-enzymic,
enzymic and biological methods. We also collaborate with other
laboratories as needed to develop new products or distribute our
products.
We take pride in providing quality stable isotopes in support of a wide
range of scientific research programs worldwide. Our research activities
frequently result in publication in peer-reviewed scientific journals,
either independently or in conjunction with other research groups. We
are a flexible research and development company, with both activities
receiving equal weight and attention.
Our company name, Omicron, is the greek letter meaning "small".
Congruent with our name, our mission is to maintain a compact and
efficient biotechnology enterprise dedicated to providing trusted
research support and state-of-the-art products for our customers, and a
growth environment for our employees.
United States
